Extent of resection as a prognostic variable in the treatment of gliomas

Journal of Neuro-Oncology

Volumn 42, Issue 3, 1999, Pages 227-231

  Hess, Kenneth R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bias; Extent; Glioma; Prognostic; Resection; Survival

Indexed keywords

ARTICLE; CANCER SURVIVAL; GLIOMA; HUMAN; MEDICAL LITERATURE; NEUROSURGERY; PATIENT SELECTION; PROGNOSIS;

BRAIN NEOPLASMS; GLIOMA; HUMANS; PROGNOSIS; TREATMENT OUTCOME;

EID: 0033024312     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006118018770     Document Type: Article

References (23)

1. Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytoma in adults. J Neurosurg 73: 331-344, 1990
2. Quigley MR, Maroon JC: The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery 29: 385-389, 1991
3. Salcman M: Surgery for malignant gliomas. In: Morantz RA, Walsh JW (eds) Brain Tumors: A Comprehensive Text. Marcel Dekker, New York, 1994, pp 417-427
4. Cohadon F: Indications for surgery in the management of gliomas. Adv Tech Stand Neurosurg 17: 189-234, 1990
5. Nitta T, Sato K: Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 75: 2727-2731, 1995
6. Kelly PJ, Hunt C: The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery 34: 62-67, 1994
7. Devaux BC, O'Fallon JR, Kelly PJ: Resection, biopsy, and survival in malignant glial neoplasms: a retrospective study of clinical parameters, therapy and outcome. J Neurosurg 78: 767-775, 1993
8. Bruner JM: Neuropathology of malignant gliomas. Seminars in Oncology 21: 126-138, 1994
9. Wood JR, Green SB, Shapiro WR: The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. J Clin Oncol 6: 338-343, 1988
10. Kiwit JCW, Floeth FW, Bock WJ: Survival in malignant glioma: analysis of prognostic factors with special regard to cytoreductive surgery. Zentralbl Neurochir 57: 76-88, 1996
11. Chisholm RA, Stenning S, Hawkings TD: The accuracy of volumetric measurement of high-grade gliomas. Clinical Radiology 40: 17-21, 1989
12. Albert FK, Forsting M, Sartor K, Adams H-P, Kunze S: Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34: 45-61, 1994
13. Kreth FW, Warnke PC, Scheremet R, Ostertag CB: Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78: 762-766, 1993
14. Simon R, Altman DG: Statistical aspects of prognostic factor studies in oncology. Br J Cancer 69: 979-985, 1994
15. Curran WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Nelson DF, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Powlis WD: Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials. Journal of Neuro-Oncology 12: 219-227, 1992
16. Prados MD, Gutin PH, Phillips TL, Wara WM, Larson DA, Sneed PK, Davis RL, Ahn DK, Lamborn K, Wilson CB: Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. In J Radiation Oncology Biol Phys 23: 3-8, 1992
17. Lai D-M, Lin S-M, Tu Y-K, Kao M-C, Hung C-C: Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors. J Formos Med Assoc 92: 220-226, 1993
18. Van der Linden W: Pitfalls in randomized surgical trials. Surgery 87: 258-262, 1980
19. Gray-Donald K, Kramer MS: Causality inference in observational vs. Experimental studies: an empirical comparison. Am J Epidemiology 127: 885-892, 1988
20. Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323-1329, 1980
21. Shapiro WR, Green SB, Burger PC, Mahaley MS, Selker RG, VanGilder JC, Robertson JT, Ransohoff J, Mealey J, Strike TA, Pistenmaa DA: Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma: Brain Tumor Cooperative Group Trial 8001. J Neurosurg 71: 1-9, 1989
22. Koprowski C: Confounding factors in clinical studies of gliomas. Am J Clin Oncol 10: 293-295, 1987
23. Hutchinson TA, Boyd NF, Feinstein AR, Gonda A, Hollomby D, Rowat B: Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status 32: 661-666, 1979